Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
557.00    0.00 (0.00%)
Bid:
556.00
Ask:
557.00
Spread: 1.00 (0.18%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Form 8.3 TATE & LYLE PLC

7 Jul 2026 12:37

RNS Number : 3551L
Barclays PLC
07 July 2026
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

TATE & LYLE PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

06 Jul 2026

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

29 1/6p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

6,766,877

1.52%

4,576,373

1.03%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4,410,692

0.99%

4,704,834

1.06%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

11,177,569

2.51%

9,281,207

2.08%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

29 1/6p ordinary

Purchase

88,074

5.5895 GBP

29 1/6p ordinary

Purchase

42,530

5.5850 GBP

29 1/6p ordinary

Purchase

38,174

5.5866 GBP

29 1/6p ordinary

Purchase

36,147

5.5800 GBP

29 1/6p ordinary

Purchase

34,353

5.5875 GBP

29 1/6p ordinary

Purchase

34,335

5.5852 GBP

29 1/6p ordinary

Purchase

30,433

5.5881 GBP

29 1/6p ordinary

Purchase

30,356

5.5857 GBP

29 1/6p ordinary

Purchase

28,275

5.5900 GBP

29 1/6p ordinary

Purchase

18,267

5.5945 GBP

29 1/6p ordinary

Purchase

18,063

5.5856 GBP

29 1/6p ordinary

Purchase

9,494

5.5861 GBP

29 1/6p ordinary

Purchase

7,479

5.5893 GBP

29 1/6p ordinary

Purchase

2,813

5.5844 GBP

29 1/6p ordinary

Purchase

2,675

5.5838 GBP

29 1/6p ordinary

Purchase

637

5.5855 GBP

29 1/6p ordinary

Purchase

399

5.5898 GBP

29 1/6p ordinary

Purchase

362

5.5848 GBP

29 1/6p ordinary

Purchase

355

5.5924 GBP

29 1/6p ordinary

Purchase

1

5.6000 GBP

29 1/6p ordinary

Sale

145,754

5.5852 GBP

29 1/6p ordinary

Sale

88,590

5.5850 GBP

29 1/6p ordinary

Sale

79,194

5.5898 GBP

29 1/6p ordinary

Sale

48,381

5.5855 GBP

29 1/6p ordinary

Sale

33,464

5.5878 GBP

29 1/6p ordinary

Sale

32,598

5.5928 GBP

29 1/6p ordinary

Sale

29,794

5.5860 GBP

29 1/6p ordinary

Sale

24,217

5.5900 GBP

29 1/6p ordinary

Sale

24,216

5.5871 GBP

29 1/6p ordinary

Sale

15,765

5.5887 GBP

29 1/6p ordinary

Sale

14,352

5.5800 GBP

29 1/6p ordinary

Sale

9,312

5.5865 GBP

29 1/6p ordinary

Sale

3,666

5.6000 GBP

29 1/6p ordinary

Sale

1,411

5.5861 GBP

29 1/6p ordinary

Sale

1,398

5.5867 GBP

29 1/6p ordinary

Sale

1,373

5.6025 GBP

29 1/6p ordinary

Sale

1,284

5.5870 GBP

29 1/6p ordinary

Sale

1,016

5.5896 GBP

29 1/6p ordinary

Sale

929

5.5868 GBP

29 1/6p ordinary

Sale

695

5.5888 GBP

29 1/6p ordinary

Sale

632

5.5875 GBP

29 1/6p ordinary

Sale

500

5.5922 GBP

29 1/6p ordinary

Sale

487

5.5917 GBP

29 1/6p ordinary

Sale

477

5.5946 GBP

29 1/6p ordinary

Sale

247

5.5891 GBP

29 1/6p ordinary

Sale

159

5.5942 GBP

29 1/6p ordinary

Sale

104

5.5840 GBP

29 1/6p ordinary

Sale

68

5.5876 GBP

29 1/6p ordinary

Sale

20

5.5950 GBP

29 1/6p ordinary

Sale

17

5.5901 GBP

29 1/6p ordinary

Sale

7

5.5969 GBP

29 1/6p ordinary

Sale

6

5.5775 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

29 1/6p ordinary

SWAP

Decreasing Long

2,692

5.5899 GBP

29 1/6p ordinary

SWAP

Decreasing Long

1,754

5.5899 GBP

29 1/6p ordinary

SWAP

Decreasing Long

70,562

5.5884 GBP

29 1/6p ordinary

SWAP

Decreasing Long

525

5.5898 GBP

29 1/6p ordinary

SWAP

Opening Short

33,303

5.5875 GBP

29 1/6p ordinary

SWAP

Increasing Short

18,419

5.5866 GBP

29 1/6p ordinary

SWAP

Increasing Short

19,755

5.5866 GBP

29 1/6p ordinary

SWAP

Increasing Long

37,286

5.5850 GBP

29 1/6p ordinary

SWAP

Opening Long

20

5.5945 GBP

29 1/6p ordinary

SWAP

Increasing Long

11,500

5.5887 GBP

29 1/6p ordinary

SWAP

Decreasing Short

13,805

5.5882 GBP

29 1/6p ordinary

CFD

Increasing Short

40,508

5.5918 GBP

29 1/6p ordinary

CFD

Increasing Short

97

5.5903 GBP

29 1/6p ordinary

CFD

Decreasing Short

48,381

5.5855 GBP

29 1/6p ordinary

SWAP

Decreasing Short

13

5.5830 GBP

29 1/6p ordinary

SWAP

Increasing Long

1,056

5.5921 GBP

29 1/6p ordinary

SWAP

Decreasing Short

929

5.5868 GBP

29 1/6p ordinary

SWAP

Decreasing Long

9,071

5.5854 GBP

29 1/6p ordinary

SWAP

Closing Long

20

5.5852 GBP

29 1/6p ordinary

SWAP

Opening Short

23,810

5.5852 GBP

29 1/6p ordinary

SWAP

Increasing Short

29,895

5.5868 GBP

29 1/6p ordinary

CFD

Increasing Short

26,946

5.5896 GBP

29 1/6p ordinary

CFD

Decreasing Short

4,818

5.5887 GBP

29 1/6p ordinary

CFD

Decreasing Short

4,544

5.5900 GBP

29 1/6p ordinary

SWAP

Decreasing Short

4

5.5850 GBP

29 1/6p ordinary

SWAP

Closing Short

32,374

5.5850 GBP

29 1/6p ordinary

SWAP

Opening Long

16,220

5.5850 GBP

29 1/6p ordinary

SWAP

Decreasing Long

1,258

5.5900 GBP

29 1/6p ordinary

SWAP

Increasing Short

20

5.5900 GBP

29 1/6p ordinary

SWAP

Decreasing Short

2,981

5.5865 GBP

29 1/6p ordinary

CFD

Decreasing Short

2,853

5.5850 GBP

29 1/6p ordinary

SWAP

Decreasing Short

4

5.5898 GBP

29 1/6p ordinary

SWAP

Increasing Long

9,074

5.5886 GBP

29 1/6p ordinary

SWAP

Decreasing Short

22,359

5.5855 GBP

29 1/6p ordinary

SWAP

Decreasing Short

48,653

5.5850 GBP

29 1/6p ordinary

CFD

Decreasing Short

49,180

5.5850 GBP

29 1/6p ordinary

SWAP

Increasing Long

100

5.5900 GBP

29 1/6p ordinary

SWAP

Closing Short

1,471

5.5850 GBP

29 1/6p ordinary

SWAP

Decreasing Short

5,613

5.5900 GBP

29 1/6p ordinary

SWAP

Increasing Long

1,063

5.5863 GBP

29 1/6p ordinary

SWAP

Decreasing Short

1,411

5.5861 GBP

29 1/6p ordinary

SWAP

Increasing Long

1,016

5.5895 GBP

29 1/6p ordinary

SWAP

Decreasing Short

29,794

5.5860 GBP

29 1/6p ordinary

SWAP

Increasing Long

2,505

5.5900 GBP

29 1/6p ordinary

SWAP

Increasing Short

333

5.5850 GBP

29 1/6p ordinary

SWAP

Decreasing Long

309

5.5850 GBP

29 1/6p ordinary

SWAP

Increasing Long

33,464

5.5878 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

07 Jul 2026

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETBBGDRUDGDGLR
Date   Source Headline
15th May 202610:24 amBUSDimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
15th May 20268:56 amRNSForm 8.5 (EPT/RI)
14th May 20264:15 pmRNSPossible 595 pence all-cash offer for Tate & Lyle
14th May 20263:25 pmRNSForm 8.3 - Tate & Lyle plc
14th May 20261:24 pmRNSDisclosure Table
14th May 20261:07 pmRNSStatement re Possible Offer for Tate & Lyle
1st May 202610:00 amRNSTotal Voting Rights
1st Apr 20264:00 pmRNSHolding(s) in Company
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration
6th Nov 20257:00 amRNSHalf-year Financial Report
5th Nov 20252:15 pmRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSHolding(s) in Company
29th Oct 20252:00 pmRNSHolding(s) in Company
23rd Oct 20254:15 pmRNSHolding(s) in Company
21st Oct 20253:30 pmRNSHolding(s) in Company
16th Oct 202512:00 pmRNSHolding(s) in Company
8th Oct 202512:00 pmRNSHolding(s) in Company
6th Oct 20254:30 pmRNSDirector/PDMR Shareholding
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 202510:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSPre-close statement
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.